Malignant perivascular epithelioid cell tumor (PEComa) of uterus: A case report with literature review

Research output: Contribution to journalReview articlepeer-review

Abstract

Perivascular epithelioid cell tumor (PEComa) is a rare mesenchymal neoplasm involving various organs. Approximately 70 cases of gynecologic PEComas have been reported in the literature. Due to the paucity of cases, there is no definite treatment regimen established. We describe disease progression in a case of uterine PEComa with pulmonary metastasis in a 37-year-old woman who had been treated with surgery and various regimens of adjuvant treatment including vincristine, ifosfamide, cisplatin, sirolimus, doxorubicin, olaratumab, pazopanib and dacarbazine. Adequate management and prognosis still seem inconclusive and further case reports with randomized trials are needed to delineate the nature of this neoplasm.

Original languageEnglish
Pages (from-to)495-499
Number of pages5
JournalEuropean Journal of Gynaecological Oncology
Volume41
Issue number4
DOIs
StatePublished - 15 Aug 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adjuvant chemotherapy
  • Dacarbazine
  • Perivascular epithelioid cell tumor (PEComa)
  • Sirolimus
  • Uterus
  • Vincristine

Fingerprint

Dive into the research topics of 'Malignant perivascular epithelioid cell tumor (PEComa) of uterus: A case report with literature review'. Together they form a unique fingerprint.

Cite this